U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07814508) titled 'Changes in Person-reported Outcomes and Behavior Using the Accu-Chek SmartGuide CGM and Predict App' on Sept. 05.

Brief Summary: The goal of this controlled pre-post-trial is to test the Accu-Chek SmartGuide continuous glucose monitoring (CGM) system and whether its predictive features provide additional benefits for adults with type 1 diabetes or insulin- treated type 2 diabetes.

The main questions this study aims to answer are:

* Does using the Accu-Chek SmartGuide together with the Predict App change participants' fear of hypoglycemia?

* Does the Predict App affect other psychological and behavioral outcomes, such as sleep qu...